Product Reports Resources Pricing Login Book a demo

Scientia Vascular

Health Tech & Medtech · West Valley City, United States · Founded 2007

Innovative neurovascular devices utilizing advanced micromachining for precise clot removal and smoother navigation MoreLess

Scientia Vascular, founded in 2007 and headquartered in Salt Lake City, specializes in developing advanced neurovascular devices. The company leverages cutting-edge micromachining technology to create high-precision guidewires and catheters, primarily serving healthcare providers in the neurovascular treatment space. Their flagship products, such as the Colossus Guidewire and the 38 Aspiration Catheter, are designed to minimize the ledge effect and enhance navigation through the vasculature, thereby improving clot removal outcomes. Scientia Vascular operates in the medical technology market, focusing on innovation and quality to maintain a competitive edge. The company generates revenue through the sale of its FDA-cleared medical devices, targeting hospitals and specialized medical centers. Key milestones include the FDA clearance of their first product in 2014 and subsequent advancements in microfabrication technology. The company benefits from its strategic location in Salt Lake City, which offers access to a rich talent pool and a burgeoning medical technology sector. Keywords: neurovascular, micromachining, guidewires, catheters, clot removal, FDA-cleared, medical devices, innovation, healthcare, Salt Lake City.

Company overview

Scientia Vascular company information

The essential company record, classifications and operating signals in one place.

Status
Acquired
Founded
2007
Headquarters
West Valley City, United States
Employees
166
Open positions
18
Dealroom signal
73.5
client focusb2btechnologyDeep Techsub industryMedical Devicesbusiness modelManufacturingindustryHealthsectorMedical & HealthcaresectorSurgerysectorNeurologysectorCatheterssectorSurgical EquipmentsectorTech for Hospitals and Clinicssectorbiotech medtech and e-healthsectorDT and LSsectorscience-based

Valuation & funding

Scientia Vascular funding history

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
ACQUISITIONOther financing Mar 2026 $550M $550M Medtronic
LATE VCOther financing Sep 2024 $14M $56M Piper Sandler
DEBTDebt Jan 2022 $25M Armentum Partners
GROWTH EQUITY VCOther financing May 2021 $50M Vivo Capital
Showing 4 recorded eventsUnlock the complete deal history →

Growth signals

Scientia Vascular website traffic

Latest recorded traffic for Scientia Vascular is 3.8K monthly website visits, up 46.2% over the last three months. Scientia Vascular's team declined 0.6% over the past year.

Latest monthly visits3.8K 3-month web change+46.2% 1-year team growth-0.6%
Monthly website visits55 observations · Oct 2020–Jul 2026
Hover or focus a point to see its exact monthly valueCompare with peers →

Comparisons

Scientia Vascular compared with similar companies

Dealroom’s weighted taxonomy model identifies the closest operating peers. Company identity and context stay open; selected comparison metrics preview what is available in the platform.

Showing 8 of the closest matchesCompare every metric →

Talent graph

Scientia Vascular's talent

Book a demo to see the people
Team profiled 3 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 2 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Investors

4 investors on Scientia Vascular's cap table

Sourced from Dealroom's funding and investor records. Investor profile links are shown where available.

Series B+ 3 investors entered at this stage
Vivo Capital
Armentum Partners
Piper Sandler
Other known 1 additional known investor
Medtronic

Global footprint

Where Scientia Vascular has talent and traffic

Workforce by country
2 countries with
team presence
🇺🇸 United States99.2%
🇨🇦 Canada0.8%
2 countries shown

In the news

Latest news about Scientia Vascular

Recent press, funding announcements, and product moves mentioning Scientia Vascular — open to read from the original sources.

See all news

Market sentiment

What the market is saying about Scientia Vascular

An AI-synthesized read of the highest-engagement posts about Scientia Vascular on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Scientia Vascular’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.